Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
P3 Health Partners ( (PIII) ) just unveiled an update.
On February 13, 2025, P3 Health Partners announced its initial financial guidance for the fiscal year ending December 31, 2025, projecting revenues between $1.350 billion and $1.500 billion and an Adjusted EBITDA ranging from negative $35 million to $5 million. The company also revealed a proposed financing transaction with its largest shareholder involving a $30 million unsecured promissory note. CEO Aric Coffman emphasized the company’s strong progress in executing its $130+ million EBITDA growth initiatives and targeting profitability in 2025, while the proposed financing is expected to provide sufficient liquidity for working capital needs.
More about P3 Health Partners
P3 Health Partners Inc. is a prominent population health management company focused on transforming healthcare by enhancing the lives of both patients and providers. The company operates with a network of over 3,100 affiliated primary care providers across the United States, offering value-based care coordination and administrative services to improve patient outcomes and reduce costs.
YTD Price Performance: -18.80%
Average Trading Volume: 2,214,651
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $72.84M
For an in-depth examination of PIII stock, go to TipRanks’ Stock Analysis page.
